Oxygen therapy remains a cornerstone in the management of chronic and acute respiratory conditions, including hypoxemia, COPD exacerbations, and interstitial lung disease. Pulmonary oxygen therapy advisor focuses on designing individualized oxygen delivery strategies, optimizing flow rates, delivery devices, and therapy schedules to achieve targeted oxygenation while minimizing complications. Responsibilities include assessing patient-specific respiratory needs, integrating arterial blood gas and pulse oximetry data, and ensuring therapy aligns with current evidence-based guidelines. Beyond patient assessment, the advisor coordinates with respiratory therapists, pulmonologists, and critical care teams to implement safe and efficient oxygen delivery across clinical settings. Advanced technologies, including high-flow nasal cannula systems, portable oxygen concentrators, and integrated monitoring devices, are evaluated and incorporated to enhance precision, mobility, and patient adherence. Pulmonary oxygen therapy advisor also develops institutional protocols, standard operating procedures, and staff training programs to ensure consistent and safe administration of oxygen therapy. Continuous monitoring, outcome tracking, and data-driven quality improvement initiatives are employed to evaluate therapy effectiveness, prevent complications such as oxygen toxicity, and support optimal respiratory function. By combining clinical expertise, technological assessment, and interprofessional coordination, the advisor ensures that oxygen therapy is delivered safely, efficiently, and effectively, improving patient well-being, facilitating functional independence, and supporting long-term respiratory health for individuals with complex pulmonary conditions.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal